18 May 2021 (Tuesday)
19:00-20:00 HKT

As many as one in five individuals will develop heart failure (HF) over their lifetime. Current gaps in drug recommendation have resulted in undertreatment for HF with reduced ejection fraction (HFrEF). Meanwhile, SGLT2 inhibitors have progressed from a diabetic indication into one with cardioprotective and renoprotective effects.

This Webinar presents an evidence-based overview of HF prevention and management for doctors, and addresses your concerns in a Q&A session among colleagues.

Speaker:

Dr CHEONG Yan Yue, Adrian
Specialist in Cardiology
Honorary Clinical Assistant Professor, The Chinese University of Hong Kong

Moderator:

Dr CHEN Wai Chee, Walter
Specialist in Cardiology

Notes

  • CME survey link will be posted at the end of the webinar
  • The webinar will held via Zoom. Login credentials will be emailed to you instantly when you register online.
  • Please register with your FULL NAME to facilitate CME registration.

Enquiry: 3893 6222 (WhatsApp/call)

  • Hong Kong College of Paediatricians: 1 point for Cat A passive
  • The Hong Kong College of Orthopaedic Surgeons: complete the form Application for Non-FCAA CME/CPD Accreditation Fellow downloaded from https://www.hkcos.org.hk/FG_Forms.asp, which should be submitted to College Secretariat directly, together with attendance proof, including (1) screenshot of the event (2) screenshot of the auto confirmation reply received after post-event survey

Supported by:

AstraZeneca_logo